PubMed 23. Odeh
M, Sabo E, Srugo I, Oliven A: Relationship between tumor necrosis factor-a and ammonia in patients with hepatic encephalopathy due to chronic liver failure. Ann Med 2005, 37: 603–612.CrossRefPubMed 24. Falasca K, Ucciferri C, Dalessandro M, Zingariello P, Mancino P, Petrarca C, Pizzigallo E, Conti P, Vecchiet J: Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 2006, 36: 144–150.PubMed 25. Cua IH, Hui JM, Bandara P, Kench JG, Farrell GC, McCaughan Selleckchem Ipatasertib GW, George J: Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology 2007, 46: 66–73.CrossRefPubMed 26. Elsammak M, Refai W, Elsawaf A, Abdel-Fattah I, Abd Elatti E, Ghazal A: Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients. Curr Med Res Opin 2005, 21: 527–534.CrossRefPubMed 27. Kamal SM, Turner B, He Q, Rasenack J,
Bianchi L, Al Tawil A, Nooman A, Massoud M, Koziel MJ, Afdhal NH: Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers Quizartinib datasheet of fibrosis. Hepatology 2006, 43: 771–779.CrossRefPubMed 28. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY: Activation of tumor necrosis factor a system in chronic hepatitis C virus infection. Dig Dis Sci 1997, 42: 2487–2494.CrossRefPubMed 29. Aderka D, Wysenbeek A, Engelmann H, Cope AP, Brennan F, Molad Y, Hornik V, Levo Y, Maini RN, Feldmann M, et al.: Correlation between serum levels of selleck chemicals llc soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993, 36: 1111–1120.CrossRefPubMed
30. Kallinowski B, Haseroth K, Marinos G, Hanck C, Stremmel W, Theilmann L, Singer MV, Rossol S: Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998, 111: 269–277.CrossRefPubMed 31. Zylberberg H, Rimaniol AC, Pol S, Masson A, De Groote D, Berthelot P, Bach JF, Bréchot C, Zavala F: Soluble tumor necrosis factor receptors Tenofovir mouse in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol 1999, 30: 185–191.CrossRefPubMed 32. Kaplanski G, Marin V, Maisonobe T, Sbai A, Farnarier C, Ghillani P, Thirion X, Durand JM, Harlé JR, Bongrand P, Piette JC, Cacoub P: Increased soluble p55 and p75 tumour necrosis factor-a receptors in patients with hepatitis C-associated mixed cryoglobulinaemia. Clin Exp Immunol 2002, 127: 123–130.CrossRefPubMed 33. Kubo F, Ueno S, Hiwatashi K, Sakoda M, Kawaida K, Nuruki K, Aikou T: Interleukin 8 in Human Hepatocellular Carcinoma Correlates With Cancer Cell Invasion of Vessels But Not With Tumor Angiogenesis. Ann Surg Oncol 2005, 12: 800–807.CrossRefPubMed 34. Schwartz M, Roayaie S, Konstadoulakis M: Strategies for the management of hepatocellular carcinoma.